Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001317828 | SCV001508505 | uncertain significance | Andersen Tawil syndrome; Short QT syndrome type 3 | 2020-08-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with KCNJ2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the KCNJ2 gene (p.Asp405Thrfs*2). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 23 amino acids of the KCNJ2 protein. |